Management of high-risk colonoscopy patients.
Rapidly evolving knowledge of the pathogenesis and natural history of colorectal cancer (CRC), especially in high-risk groups, is allowing the development of new tools to identify those who will benefit most from preventive measures. Currently, screening for adenomas, dysplasia, and early-stage invasive cancers provides the best opportunity to prevent and improve survival from CRC. Screening of high-risk groups almost always includes colonoscopy. This review discusses what represents quality colonoscopy. Proper risk stratification, understanding the natural history of each disease, proper patient counseling, and optimal techniques all help define quality colonoscopy in high-risk groups.
Bresalier
Robert S
RS
Department of Gastroenterology, Hepatology and Nutrition, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1466, Houston, TX 77030-4009, USA. rbresali@mdanderson.org
D011125:Adenomatous Polyposis Coli / Q000175:diagnosis / Q000453:epidemiology; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000453:epidemiology* / Q000517:prevention & control; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000175:diagnosis / Q000453:epidemiology; D055088:Early Detection of Cancer; D020022:Genetic Predisposition to Disease; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis / Q000453:epidemiology; D008403:Mass Screening; D012306:Risk